MoneyWorks4Me

Lactose (India) - Quaterly Results

12 Aug 2026 Evaluate
A fair growth of 18.68% in the revenue at Rs. 469.68 millions was reported in the June 2026 quarter as compared to Rs. 395.76 millions during year-ago period.Net profit for the quarter ended June 2026 increased significantly by 57.77% to Rs. 23.65 millions from Rs. 14.99 millions.Operating profit surged to 66.35 millions from the corresponding previous quarter of 48.82 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 469.68 395.76 18.68 469.68 395.76 18.68 1632.90 1163.99 40.28
Other Income 5.60 4.15 34.94 5.60 4.15 34.94 10.72 14.54 -26.27
PBIDT 66.35 48.82 35.91 66.35 48.82 35.91 194.49 184.12 5.63
Interest 17.64 12.20 44.59 17.64 12.20 44.59 50.86 61.03 -16.66
PBDT 48.71 36.62 33.01 48.71 36.62 33.01 143.63 123.09 16.69
Depreciation 16.38 13.73 19.30 16.38 13.73 19.30 57.42 53.91 6.51
PBT 32.33 22.89 41.24 32.33 22.89 41.24 86.21 69.18 24.62
TAX 8.68 7.90 9.87 8.68 7.90 9.87 25.58 17.54 45.84
Deferred Tax 1.92 4.08 -52.94 1.92 4.08 -52.94 13.40 4.38 205.94
PAT 23.65 14.99 57.77 23.65 14.99 57.77 60.63 51.64 17.41
Equity 125.89 125.89 0.00 125.89 125.89 0.00 125.89 125.89 0.00
PBIDTM(%) 14.13 12.34 14.52 14.13 12.34 14.52 11.91 15.82 -24.70
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..